235. Hypoparathyroidism Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 88 / Drugs : 107 - (DrugBank : 24) / Drug target genes : 5 - Drug target pathways : 7
Hypoparathyroidism and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 235 | Hypoparathyroidism | - |
| 65 | Primary immunodeficiency | 4.000 |
| 326 | Osteopetrosis | 2.391 |
| 70 | Spinal stenosis | 2.284 |
| 46 | Malignant rheumatoid arthritis | 2.262 |
| 162 | Pemphigoid | 1.061 |
| 228 | Bronchiolitis obliterans | 1.061 |
| 41 | Giant cell arteritis | 1.061 |
| 66 | IgA nephropathy | 1.057 |
| 56 | Behcet disease | 1.056 |
| 98 | Eosinophilic gastrointestinal disease | 1.049 |
| 271 | Ankylosing spondylitis | 1.049 |
| 60 | Aplastic anemia | 1.048 |
| 18 | Spinocerebellar degeneration | 1.044 |
| 50 | Dermatomyositis | 1.042 |
| 107 | Juvenile idiopathic arthritis | 1.038 |
| 298 | Hereditary pancreatitis | 1.038 |
| 53 | Sjogren syndrome | 1.036 |
| 113 | Muscular dystrophy | 1.034 |
| 75 | Cushing disease | 1.032 |
| 28 | Systemic amyloidosis | 1.030 |
| 19 | Lysosomal storage disease | 1.029 |
| 84 | Sarcoidosis | 1.024 |
| 299 | Cystic fibrosis | 1.021 |
| 85 | Idiopathic interstitial pneumonia | 1.020 |
| 51 | Scleroderma | 1.018 |
| 49 | Systemic lupus erythematosus | 1.018 |
| 97 | Ulcerative colitis | 1.014 |
| 96 | Crohn disease | 1.012 |
| 6 | Parkinson disease | 1.011 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 1.008 |
| 68 | Ossification of the ligamentum flavum | 1.000 |
| 220 | Rapidly progressive glomerulonephritis | 1.000 |
| 30 | Distal myopathy | 1.000 |